...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Intramacrophage passage of Mycobacterium tuberculosis and M. avium complex alters the drug susceptibilities of the organisms as determined by intracellular susceptibility testing using macrophages and type II alveolar epithelial cells.
【24h】

Intramacrophage passage of Mycobacterium tuberculosis and M. avium complex alters the drug susceptibilities of the organisms as determined by intracellular susceptibility testing using macrophages and type II alveolar epithelial cells.

机译:通过使用巨噬细胞和II型肺泡上皮细胞的细胞内药敏试验确定,结核分枝杆菌和鸟分枝杆菌复合物的巨噬细胞内传递改变了生物体的药敏性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mycobacterium tuberculosis and M. avium complex strains given intramacrophage passage (I-type) were compared with those cultured in a liquid medium (E-type) for their drug susceptibilities when they were replicating in Mono-Mac-6 macrophages or A-549 cells. Their intracellular susceptibilities to rifalazil, clarithromycin, and levofloxacin were decreased more in I-type organisms than in E-type organisms, except that their rifalazil susceptibility inside A-549 cells was markedly increased in I-type organisms.
机译:将在巨噬细胞内通过的结核分枝杆菌和鸟分枝杆菌复杂菌株(I型)与在液体培养基(E型)中培养的菌株在Mono-Mac-6巨噬细胞或A-549细胞中复制时的药敏性进行了比较。 。在I型生物中,它们对利福拉齐,克拉霉素和左氧氟沙星的细胞内敏感性比在E型生物中降低更多,除了在I型生物中它们在A-549细胞内的利福拉齐敏感性显着增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号